George Grossberg, MD, reviews how accurate the first FDA-cleared Alzheimer blood test is and which patient factors can skew its results.
George Grossberg, MD
Advertisement
Dr Grossberg is the Henry and Amelia Nasrallah Professor in Geriatric Psychiatry at Saint Louis University School of Medicine.
Articles by George Grossberg, MD
Blood-based biomarkers are helping clinicians move past vague dementia diagnoses, but an expert says the tests belong only after a full workup in patients with objective impairment.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Defining Treatment-Resistant Depression In Adults
2
Interventional Options for TRD: ECT, TMS, and Esketamine
3
FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia
4
Vortioxetine's Effect on Cognitive Function in Older Adults With Major Depressive Disorder
5